Jpmorgan just reduced Iran’s actions. This is where the options data tell us that it could be directed below.

Iren’s actions (Iren) fell 10% today after a JPMorgan senior analyst issued a bearish note about the data center company.

On Friday, the reginald Smith analyst degraded the shares of Iran to “low weight” and announced an objective price of $ 24, indicating the potential of another 40% decrease in current levels.

Despite today’s setback, Iran’s shares are quoted more than 7 times their price in early April.

In a research note this morning, Smith cited valuation concerns to degrade Iren’s actions.

The company that is currently quoted in Nasdaq to a price gain ratio (p/e) at approximately 67x, which triumphs on the multiples in the best AI actions, even NVIDIA (NVDA), that will have only 42x.

According to the JPM analyst, the current price of the company’s shares already takes into account the scenarios too optimistic, particularly with respect to the possible placement agreement that may require more than $ 10 billion in capital expenses.

Without specific income generation agreements, the current Iren Stock premium

Barchart signal options data increased volatility in Iran’s shares with a short -term expected movement of 10.18% until the end of next week.

Looking further, contracts that expire on December 19 suggest a broader range, from $ 25.66 in the inconvenience to $ 57.18 in the rise.

While this indicates a significant upward potential, JPMorgan’s reduction highlights the risk of execution. Without income accumulation agreements to support AI and HPC’s commitment to the company, the disadvantage scenario may be more realistic.

In general, investors must weigh the speculative enthusiasm against the valuation discipline, especially as Iren’s actions work well above the average multiple of the industry.

Investors must also keep in mind that JPMorgan is not the only Wall Street company that recommends caution when buying Iren Actions at current levels.

According to Barchart, the consensus rating in Iran’s shares remains in “moderate purchase”, but the average objective of approximately $ 36 indicates a possible 10% inconvenience from here.